Imfinzi 500 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26F9F42
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,931
Award facts
- Contract value 100% obligated
- $41,930.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $41,930.85 to AmerisourceBergen Drug Corp for the supply of IMFINZI 500 mg/10 ml vials on a firm fixed-price basis. The award, issued on November 13, 2025, with an ultimate completion date of December 5, 2025, represents a non-set-aside competitive procurement. IMFINZI (durvalumab) is an immunotherapy medication used in cancer treatment, and this delivery order fulfills pharmaceutical supply requirements for military and federal healthcare systems. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement through the DLA's Medical Supply Chain.
This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's consistent competitive awards across therapeutic domains demonstrate its capability to meet stringent federal procurement standards for specialized pharmaceutical products.
Quick answers
Who was awarded contract SPE2DR26F9F42?
SPE2DR26F9F42 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 13, 2025.
How much is contract SPE2DR26F9F42 worth?
The government has obligated $41,931 on SPE2DR26F9F42.
Is contract SPE2DR26F9F42 an order under another contract?
Yes. SPE2DR26F9F42 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9F42 competed?
The extent of competition for SPE2DR26F9F42 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award